GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 1.015
NA - Nord America 824
AS - Asia 80
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 1.924
Nazione #
US - Stati Uniti d'America 823
IE - Irlanda 494
IT - Italia 199
GB - Regno Unito 100
CN - Cina 65
FR - Francia 47
DE - Germania 43
GR - Grecia 39
UA - Ucraina 37
SE - Svezia 20
FI - Finlandia 11
ES - Italia 6
IN - India 5
BE - Belgio 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
PT - Portogallo 3
SG - Singapore 3
AT - Austria 2
EU - Europa 2
KR - Corea 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AM - Armenia 1
CA - Canada 1
EG - Egitto 1
IR - Iran 1
NL - Olanda 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.924
Città #
Dublin 486
Chandler 168
Jacksonville 97
Princeton 61
Roxbury 61
Beijing 45
Cambridge 45
Naples 44
Bremen 28
New York 28
Caserta 22
Wilmington 19
Medford 18
Des Moines 17
Boardman 12
Woodbridge 8
Lappeenranta 7
Rome 7
Ashburn 6
Norwalk 6
Madrid 5
San Mateo 5
Tulsa 5
Brussels 4
Nanjing 4
Napoli 4
Palo Alto 4
Pune 4
Redwood City 4
San Martino 4
Siano 4
Ann Arbor 3
Arzano 3
Casoria 3
Ciampino 3
Fairfield 3
Helsinki 3
Jinan 3
Abano Terme 2
Ancona 2
Andover 2
Aversa 2
Bornheim 2
Changsha 2
Dunedin 2
Frankfurt am Main 2
Haikou 2
Hebei 2
Lucca 2
Lyon 2
Montesilvano Marina 2
Nanchang 2
Ningbo 2
Prague 2
Putignano 2
Redmond 2
San Gennaro Vesuviano 2
Seattle 2
Sennori 2
Turin 2
Vienna 2
Acerra 1
Ariano Irpino 1
Atlanta 1
Bagnoli Irpino 1
Bhubaneswar 1
Borest 1
Brdo 1
Brno 1
Buffalo 1
Cairo 1
Casalnuovo di Napoli 1
Düsseldorf 1
Elora 1
Fisciano 1
Frattamaggiore 1
Gunzenhausen 1
Hanover 1
Istanbul 1
Kunming 1
Lanzhou 1
London 1
Lonigo 1
Massa di Somma 1
Meuro 1
Milan 1
Montecorvino Rovella 1
Moscow 1
Mountain View 1
Munich 1
Piano di Sorrento 1
Polistena 1
Secaucus 1
Shenyang 1
Suzzara 1
West Jordan 1
Yerevan 1
Totale 1.335
Nome #
Aetiopathological mechanisms of negative symptoms in schizophrenia 73
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 65
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 60
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 57
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 45
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 44
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 44
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 43
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 43
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 42
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 40
VTA-insula connectivity and avolition in subjects with schizophrenia 40
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 40
Accuracy of self-assessment of real-life functioning in schizophrenia 39
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 37
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 36
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 36
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 36
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 36
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 35
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 35
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 35
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 34
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 34
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 34
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 33
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 33
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 32
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 32
Electrophysiological correlates of negative symptom domains in schizophrenia 29
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 29
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 29
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 29
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 29
Association of functional genetic variation in PP2A with prefrontal working memory processing 28
Neuroimaging: Diagnostic boundaries and biomarkers 27
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 26
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 26
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 25
Neurobiology of Schizophrenia: Electrophysiological indices 25
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 24
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 24
'Precision psychiatry' needs to become part of 'personalized psychiatry' 24
Relationship between MMN and real-life functioning in subjects with schizophrenia 23
MMN impairment in subjects with schizophrenia among different stages of disease 23
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 23
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 22
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 22
P3a and real-life functioning in a sample of chronic schizophrenia subjects 22
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 22
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 20
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 19
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 19
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 19
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 19
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 18
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 17
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 17
EPA guidance on assessment of negative symptoms in schizophrenia 17
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 16
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 16
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 16
EPA guidance on treatment of negative symptoms in schizophrenia 15
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 15
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 14
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 14
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 13
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 13
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 13
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 13
Worldwide initiatives aimed to train professionals in the use of the ICD-11 11
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 10
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 10
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 9
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 9
EPA Guidance on treatment of cognitive impairment in schizophrenia 9
EPA guidance on assessment of cognitive impairment in schizophrenia 8
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 7
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 6
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 6
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 5
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 4
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 3
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 2
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 2
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 2
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 2
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 1
Totale 2.153
Categoria #
all - tutte 10.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 0 9
2019/2020256 41 28 7 4 21 43 41 6 6 24 19 16
2020/2021159 2 10 7 14 17 1 35 2 14 6 38 13
2021/2022442 6 1 10 13 114 17 14 8 18 74 38 129
2022/2023834 77 26 26 43 73 55 10 29 437 11 19 28
2023/2024352 26 25 38 40 139 48 9 10 7 10 0 0
Totale 2.153